Yahoo Finance EN

Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)

Mar 10, 2026 &03021010202631; 12:02 UTC finance.yahoo.com Trending 4/5

Read original on finance.yahoo.com ↗

↗

Positive for markets

Sentiment score: +65/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Piper Sandler raised its price target for Travere Therapeutics (TVTX), signaling increased confidence in the company's growth prospects and pipeline potential. This analyst upgrade typically reflects positive developments in clinical trials, market expansion, or financial performance expectations.

AI CONFIDENCE

75% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

TVTX

TVTXStock

Expected to rise

Analyst price target increase from Piper Sandler suggests positive outlook on company fundamentals and growth trajectory

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider accumulating TVTX on any near-term weakness as the analyst upgrade validates the investment thesis. Monitor for additional analyst coverage and clinical trial updates that could further support the bullish momentum.

KEY SIGNALS

Analyst upgradePrice target increaseIncreased institutional confidencePotential pipeline catalystPositive fundamental reassessment

SECTORS INVOLVED

HealthcareBiotechnologyPharmaceuticals

Analysis generated on Mar 11, 2026 at 02:50 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Yahoo Finance. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)

RELATED INTELLIGENCE